{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:55:40Z","timestamp":1789844140130,"version":"4.0.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Yolk sac tumors (YSTs) are a major histological subtype of malignant ovarian germ cell tumors with a relatively poor prognosis. The molecular basis of this disease has not been thoroughly characterized at the genomic level. Here we perform whole-exome and RNA sequencing on 41 clinical tumor samples from 30 YST patients, with distinct responses to cisplatin-based chemotherapy. We show that microsatellite instability status and mutational signatures are informative of chemoresistance. We identify somatic driver candidates, including significantly mutated genes<jats:italic>KRAS<\/jats:italic>and<jats:italic>KIT<\/jats:italic>and copy-number alteration drivers, including deleted<jats:italic>ARID1A<\/jats:italic>and<jats:italic>PARK2<\/jats:italic>, and amplified<jats:italic>ZNF217<\/jats:italic>,<jats:italic>CDKN1B<\/jats:italic>, and<jats:italic>KRAS<\/jats:italic>. YSTs have very infrequent<jats:italic>TP53<\/jats:italic>mutations, whereas the tumors from patients with abnormal gonadal development contain both<jats:italic>KRAS<\/jats:italic>and<jats:italic>TP53<\/jats:italic>mutations. We further reveal a role of<jats:italic>OVOL2<\/jats:italic>overexpression in YST resistance to cisplatin. This study lays a critical foundation for understanding key molecular aberrations in YSTs and developing related therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41467-021-23681-0","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T10:05:00Z","timestamp":1623405900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7856-1655","authenticated-orcid":false,"given":"Xuan","family":"Zong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7633-286X","authenticated-orcid":false,"given":"Han","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1276-1136","authenticated-orcid":false,"given":"Jiaxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"23681_CR1","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1097\/IGC.0000000000000223","volume":"24","author":"J Brown","year":"2014","unstructured":"Brown, J. et al. Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors. Int J. Gynecol. Cancer 24, S48\u2013S54 (2014).","journal-title":"Int J. Gynecol. Cancer"},{"key":"23681_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5858\/arpa.2012-0547-RA","volume":"138","author":"FF Nogales","year":"2014","unstructured":"Nogales, F. F., Dulcey, I. & Preda, O. Germ cell tumors of the ovary: an update. Arch. Pathol. Lab. Med. 138, 351\u2013362 (2014).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"23681_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1365-2559.2011.03889.x","volume":"60","author":"FF Nogales","year":"2012","unstructured":"Nogales, F. F., Preda, O. & Nicolae, A. Yolk sac tumours revisited. A review of their many faces and names. Histopathology 60, 1023\u20131033 (2012).","journal-title":"Histopathology"},{"key":"23681_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-2559.1981.tb01800.x","volume":"5","author":"FA Langley","year":"1981","unstructured":"Langley, F. A. et al. Yolk sac and allied tumours of the ovary. Histopathology 5, 389\u2013401 (1981).","journal-title":"Histopathology"},{"key":"23681_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ygyno.2017.08.013","volume":"147","author":"D Nasioudis","year":"2017","unstructured":"Nasioudis, D., Chapman-Davis, E., Frey, M. K., Caputo, T. A. & Holcomb, K. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base. Gynecol. Oncol. 147, 296\u2013301 (2017).","journal-title":"Gynecol. Oncol."},{"key":"23681_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ygyno.2011.01.003","volume":"121","author":"LE Weinberg","year":"2011","unstructured":"Weinberg, L. E., Lurain, J. R., Singh, D. K. & Schink, J. C. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors. Gynecol. Oncol. 121, 285\u2013289 (2011).","journal-title":"Gynecol. Oncol."},{"key":"23681_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1387\/ijdb.130026ll","volume":"57","author":"LH Looijenga","year":"2013","unstructured":"Looijenga, L. H., Van Agthoven, T. & Biermann, K. Development of malignant germ cells - the genvironmental hypothesis. Int J. Dev. Biol. 57, 241\u2013253 (2013).","journal-title":"Int J. Dev. Biol."},{"key":"23681_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6973","volume":"6","author":"K Litchfield","year":"2015","unstructured":"Litchfield, K. et al. Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours. Nat. Commun. 6, 5973 (2015).","journal-title":"Nat. Commun."},{"key":"23681_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1210\/er.2012-1045","volume":"34","author":"SM Kraggerud","year":"2013","unstructured":"Kraggerud, S. M. et al. Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis. Endocr. Rev. 34, 339\u2013376 (2013).","journal-title":"Endocr. Rev."},{"key":"23681_CR10","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","volume":"23","author":"H Shen","year":"2018","unstructured":"Shen, H. et al. Integrated molecular characterization of testicular germ cell tumors. Cell Rep. 23, 3392\u20133406 (2018).","journal-title":"Cell Rep."},{"key":"23681_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature20596","volume":"540","author":"A Taylor-Weiner","year":"2016","unstructured":"Taylor-Weiner, A. et al. Genomic evolution and chemoresistance in germ-cell tumours. Nature 540, 114\u2013118 (2016).","journal-title":"Nature"},{"key":"23681_CR12","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1158\/0008-5472.CAN-12-2876","volume":"73","author":"M Gutekunst","year":"2013","unstructured":"Gutekunst, M. et al. Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4. Cancer Res. 73, 1460\u20131469 (2013).","journal-title":"Cancer Res."},{"key":"23681_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2350\/08-05-0097.1","volume":"9","author":"MK Fritsch","year":"2006","unstructured":"Fritsch, M. K., Schneider, D. T., Schuster, A. E., Murdoch, F. E. & Perlman, E. J. Activation of Wnt\/beta-catenin signaling in distinct histologic subtypes of human germ cell tumors. Pediatr. Dev. Pathol. 9, 115\u2013131 (2006).","journal-title":"Pediatr. Dev. Pathol."},{"key":"23681_CR14","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1111\/j.1365-2605.2011.01186.x","volume":"34","author":"N Fustino","year":"2011","unstructured":"Fustino, N., Rakheja, D., Ateek, C. S., Neumann, J. C. & Amatruda, J. F. Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours. Int J. Androl. 34, e218\u201333 (2011).","journal-title":"Int J. Androl."},{"key":"23681_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ygyno.2016.07.005","volume":"142","author":"T de la Motte Rouge","year":"2016","unstructured":"de la Motte Rouge, T. et al. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors. Gynecol. Oncol. 142, 452\u2013457 (2016).","journal-title":"Gynecol. Oncol."},{"key":"23681_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cels.2018.03.002","volume":"6","author":"K Ellrott","year":"2018","unstructured":"Ellrott, K. et al. Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Syst. 6, 271\u2013281 e7 (2018).","journal-title":"Cell Syst."},{"key":"23681_CR17","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.18632\/oncotarget.13918","volume":"8","author":"EA Kautto","year":"2017","unstructured":"Kautto, E. A. et al. Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS. Oncotarget 8, 7452\u20137463 (2017).","journal-title":"Oncotarget"},{"key":"23681_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"CM Ribic","year":"2003","unstructured":"Ribic, C. M. et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 349, 247\u2013257 (2003).","journal-title":"N. Engl. J. Med."},{"key":"23681_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"23681_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ng.3557","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim, J. et al. Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors. Nat. Genet. 48, 600\u2013606 (2016).","journal-title":"Nat. Genet"},{"key":"23681_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371\u2013385 e18 (2018).","journal-title":"Cell"},{"key":"23681_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218 (2013).","journal-title":"Nature"},{"key":"23681_CR23","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput. Biol. 12, e1004873 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"23681_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"23681_CR25","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ng.2760","volume":"45","author":"TI Zack","year":"2013","unstructured":"Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134\u20131140 (2013).","journal-title":"Nat. Genet."},{"key":"23681_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/humu.21377","volume":"32","author":"L Gremer","year":"2011","unstructured":"Gremer, L. et al. Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders. Hum. Mutat. 32, 33\u201343 (2011).","journal-title":"Hum. Mutat."},{"key":"23681_CR27","doi-asserted-by":"publisher","first-page":"eaar8371","DOI":"10.1126\/scisignal.aar8371","volume":"11","author":"E Sheffels","year":"2018","unstructured":"Sheffels, E. & et al. Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation. Sci. Signal. 11, eaar8371 (2018).","journal-title":"Sci. Signal."},{"key":"23681_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/35618","volume":"391","author":"CS Raymond","year":"1998","unstructured":"Raymond, C. S. et al. Evidence for evolutionary conservation of sex-determining genes. Nature 391, 691\u2013695 (1998).","journal-title":"Nature"},{"key":"23681_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ajhg.2013.03.002","volume":"92","author":"AG Marneros","year":"2013","unstructured":"Marneros, A. G. et al. Mutations in KCTD1 cause scalp-ear-nipple syndrome. Am. J. Hum. Genet. 92, 621\u2013626 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"23681_CR30","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio, F. et al. A landscape of pharmacogenomic interactions in cancer. Cell 166, 740\u2013754 (2016).","journal-title":"Cell"},{"key":"23681_CR31","first-page":"2758","volume":"62","author":"F Mayer","year":"2002","unstructured":"Mayer, F. et al. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. Cancer Res. 62, 2758\u20132760 (2002).","journal-title":"Cancer Res."},{"key":"23681_CR32","first-page":"4319","volume":"25","author":"J Olasz","year":"2005","unstructured":"Olasz, J. et al. Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors. Anticancer Res. 25, 4319\u20134324 (2005).","journal-title":"Anticancer Res."},{"key":"23681_CR33","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1200\/JCO.2008.18.8623","volume":"27","author":"F Honecker","year":"2009","unstructured":"Honecker, F. et al. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. J. Clin. Oncol. 27, 2129\u20132136 (2009).","journal-title":"J. Clin. Oncol."},{"key":"23681_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0378-1119(98)00334-5","volume":"216","author":"PK Grewal","year":"1998","unstructured":"Grewal, P. K., Todd, L. C., van der Maarel, S., Frants, R. R. & Hewitt, J. E. FRG1, a gene in the FSH muscular dystrophy region on human chromosome 4q35, is highly conserved in vertebrates and invertebrates. Gene 216, 13\u201319 (1998).","journal-title":"Gene"},{"key":"23681_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1242\/dmm.002261","volume":"2","author":"RD Wuebbles","year":"2009","unstructured":"Wuebbles, R. D., Hanel, M. L. & Jones, P. L. FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy. Dis. Model Mech. 2, 267\u2013274 (2009).","journal-title":"Dis. Model Mech."},{"key":"23681_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.humpath.2018.04.005","volume":"78","author":"M Mehrad","year":"2018","unstructured":"Mehrad, M., LaFramboise, W. A., Lyons, M. A., Trejo Bittar, H. E. & Yousem, S. A. Whole-exome sequencing identifies unique mutations and copy number losses in calcifying fibrous tumor of the pleura: report of 3 cases and review of the literature. Hum. Pathol. 78, 36\u201343 (2018).","journal-title":"Hum. Pathol."},{"key":"23681_CR37","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jamcollsurg.2018.01.059","volume":"226","author":"NJ Erinjeri","year":"2018","unstructured":"Erinjeri, N. J., Nicolson, N. G., Deyholos, C., Korah, R. & Carling, T. Whole-exome sequencing identifies two discrete druggable signaling pathways in follicular thyroid cancer. J. Am. Coll. Surg. 226, 950\u2013959 e5 (2018).","journal-title":"J. Am. Coll. Surg."},{"key":"23681_CR38","doi-asserted-by":"publisher","first-page":"BSR20171062","DOI":"10.1042\/BSR20171062","volume":"37","author":"A Tiwari","year":"2017","unstructured":"Tiwari, A., Pattnaik, N., Mohanty Jaiswal, A. & Dixit, M. Increased FSHD region gene1 expression reduces in vitro cell migration, invasion, and angiogenesis, ex vivo supported by reduced expression in tumors. Biosci. Rep. 37, BSR20171062 (2017).","journal-title":"Biosci. Rep."},{"key":"23681_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5509-4","volume":"19","author":"A Tiwari","year":"2019","unstructured":"Tiwari, A. et al. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion. BMC Cancer 19, 346 (2019).","journal-title":"BMC Cancer"},{"key":"23681_CR40","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1093\/nar\/19.14.3996","volume":"19","author":"HJ Thiesen","year":"1991","unstructured":"Thiesen, H. J., Bellefroid, E., Revelant, O. & Martial, J. A. Conserved KRAB protein domain identified upstream from the zinc finger region of Kox 8. Nucleic Acids Res. 19, 3996 (1991).","journal-title":"Nucleic Acids Res."},{"key":"23681_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ydbio.2005.12.003","volume":"291","author":"DR Mackay","year":"2006","unstructured":"Mackay, D. R., Hu, M., Li, B., Rheaume, C. & Dai, X. The mouse Ovol2 gene is required for cranial neural tube development. Dev. Biol. 291, 38\u201352 (2006).","journal-title":"Dev. Biol."},{"key":"23681_CR42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1365-2443.2007.01084.x","volume":"12","author":"S Unezaki","year":"2007","unstructured":"Unezaki, S., Horai, R., Sudo, K., Iwakura, Y. & Ito, S. Ovol2\/Movo, a homologue of Drosophila ovo, is required for angiogenesis, heart formation and placental development in mice. Genes Cells 12, 773\u2013785 (2007).","journal-title":"Genes Cells"},{"key":"23681_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.devcel.2014.03.006","volume":"29","author":"K Watanabe","year":"2014","unstructured":"Watanabe, K. et al. Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor. Dev. Cell 29, 59\u201374 (2014).","journal-title":"Dev. Cell"},{"key":"23681_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.devcel.2014.03.005","volume":"29","author":"B Lee","year":"2014","unstructured":"Lee, B. et al. Transcriptional mechanisms link epithelial plasticity to adhesion and differentiation of epidermal progenitor cells. Dev. Cell 29, 47\u201358 (2014).","journal-title":"Dev. Cell"},{"key":"23681_CR45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1053\/j.gastro.2015.11.041","volume":"150","author":"GD Ye","year":"2016","unstructured":"Ye, G. D. et al. OVOL2, an inhibitor of WNT signaling, reduces invasive activities of human and mouse cancer cells and is down-regulated in human colorectal tumors. Gastroenterology 150, 659\u2013671 e16 (2016).","journal-title":"Gastroenterology"},{"key":"23681_CR46","doi-asserted-by":"publisher","first-page":"39401","DOI":"10.18632\/oncotarget.17031","volume":"8","author":"RS Wu","year":"2017","unstructured":"Wu, R. S. et al. OVOL2 antagonizes TGF-beta signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis. Oncotarget 8, 39401\u201339416 (2017).","journal-title":"Oncotarget"},{"key":"23681_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2016.11.034","volume":"600","author":"ZH Wang","year":"2017","unstructured":"Wang, Z. H. et al. Ovol2 gene inhibits the epithelial-to-mesenchymal transition in lung adenocarcinoma by transcriptionally repressing Twist1. Gene 600, 1\u20138 (2017).","journal-title":"Gene"},{"key":"23681_CR48","doi-asserted-by":"publisher","first-page":"794","DOI":"10.21037\/tau.2016.08.09","volume":"5","author":"M Kathrins","year":"2016","unstructured":"Kathrins, M. & Kolon, T. F. Malignancy in disorders of sex development. Transl. Androl. Urol. 5, 794\u2013798 (2016).","journal-title":"Transl. Androl. Urol."},{"key":"23681_CR49","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"23681_CR50","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"23681_CR51","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1093\/bioinformatics\/btw239","volume":"32","author":"PP Wang","year":"2016","unstructured":"Wang, P. P., Parker, W. T., Branford, S. & Schreiber, A. W. BAM-matcher: a tool for rapid NGS sample matching. Bioinformatics 32, 2699\u20132701 (2016).","journal-title":"Bioinformatics"},{"key":"23681_CR52","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","volume":"173","author":"F Sanchez-Vega","year":"2018","unstructured":"Sanchez-Vega, F. et al. Oncogenic signaling pathways in the cancer genome atlas. Cell 173, 321\u2013337 e10 (2018).","journal-title":"Cell"},{"key":"23681_CR53","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/ng.3934","volume":"49","author":"P Polak","year":"2017","unstructured":"Polak, P. et al. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer. Nat. Genet. 49, 1476\u20131486 (2017).","journal-title":"Nat. Genet."},{"key":"23681_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0893-4","volume":"17","author":"R Rosenthal","year":"2016","unstructured":"Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).","journal-title":"Genome Biol."},{"key":"23681_CR55","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1373\/clinchem.2014.223677","volume":"60","author":"SJ Salipante","year":"2014","unstructured":"Salipante, S. J., Scroggins, S. M., Hampel, H. L., Turner, E. H. & Pritchard, C. C. Microsatellite instability detection by next generation sequencing. Clin. Chem. 60, 1192\u20131199 (2014).","journal-title":"Clin. Chem."},{"key":"23681_CR56","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D. C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756 (2018).","journal-title":"Genome Res."},{"key":"23681_CR57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498 (2011).","journal-title":"Nat. Genet."},{"key":"23681_CR58","doi-asserted-by":"publisher","first-page":"e1003665","DOI":"10.1371\/journal.pcbi.1003665","volume":"10","author":"CA Miller","year":"2014","unstructured":"Miller, C. A. et al. SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput. Biol. 10, e1003665 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"23681_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14114","volume":"8","author":"JG Reiter","year":"2017","unstructured":"Reiter, J. G. et al. Reconstructing metastatic seeding patterns of human cancers. Nat. Commun. 8, 14114 (2017).","journal-title":"Nat. Commun."},{"key":"23681_CR60","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/molbev\/msw054","volume":"33","author":"S Kumar","year":"2016","unstructured":"Kumar, S., Stecher, G. & Tamura, K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 33, 1870\u20131874 (2016).","journal-title":"Mol. Biol. Evol."},{"key":"23681_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).","journal-title":"Genome Biol."},{"key":"23681_CR62","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562\u2013578 (2012).","journal-title":"Nat. Protoc."},{"key":"23681_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).","journal-title":"Genome Biol."},{"key":"23681_CR64","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23681-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T20:08:35Z","timestamp":1699128515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23681-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23681"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23681-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.P., H. Li, and X.G. are full-time employees of Precision Scientific; and H. Liang is an advisor and shareholder of Precision Scientific. All other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3579"}}